The SEMA Show is the premier automotive specialty products trade event in the world, drawing the industry’s brightest minds and hottest products to one place, the Las Vegas Convention Center. Additionally, SEMA provides attendees with educational seminars, product demonstrations, special events, networking opportunities and more. Mitchell will once again be attending SEMA as an exhibitor with an interactive exhibit booth, which can be found in the North Hall. Those visiting Mitchell’s booth will have the opportunity to be one of the first to demo the latest Mitchell solutions for the repair industry. We look forward to seeing you on the show floor! Need to schedule a meeting with a sales representative? Contact us today.
More stories
South Carolina Approves Fee Schedule Changes
April 5, 2022
The South Carolina Workers’ Compensation Commission approved changes to the Medical Services Provider Manual, effective April 1, 2022.
Mitchell Introduces New Commercial Truck Estimating Solution
April 5, 2022
Insurers and repairers can now use Mitchell’s cloud-based technology for appraisals of collision-damaged passenger and specialty vehicles, mot
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
April 4, 2022
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
March 29, 2022
Data analysis by Aarthi Thiruvengadam.
Symbicort Generic Approval on March 15, 2022
March 29, 2022
Recently the U.S. Food and Drug Administration (FDA) approved a generic formulation of Symbicort metered-dose inhaler for the treatment of asthma or chronic obstructive pulmonary disease (COPD).
The Rise of Fentanyl in the Midst of an Already Troubling Opioid Epidemic
March 24, 2022
Each day we hear more and more stories of addiction, overdose, and deaths with heartbreaking stories of the individuals and the families who have been impacted by the opioid epidemic. In an attempt to address this crisis, more aggressive clinical intervention and opioid management programs are being adopted, and opioid use has steadily decreased for workers’ compensation patients; however, according to an NSC survey, 75% of employers are being directly impacted by employee opioid misuse.